FDA Factory Approval and Relaunch of Aridol in US Market

15th Aug 18

Release Date: 15/08/2018 9:15am

Pharmaceutical research company Pharmaxis (ASX: PXS) today announced the company has received approval from the United States Food and Drug Administration (FDA) for its manufacturing facility to produce the asthma diagnostic product Aridol for the US market.

Read full media release - pdf

Categories: News and Media